Astrocytes are neural parenchymal cells that ubiquitously tile the central nervous system (CNS). In addition to playing essential roles in healthy tissue, astrocytes exhibit an evolutionarily ancient response to all CNS insults, referred to as astrocyte reactivity. Long regarded as passive and homogeneous, astrocyte reactivity is being revealed as a heterogeneous and functionally powerful component of mammalian CNS innate immunity. Nevertheless, concepts about what astrocyte reactivity comprises and what it does are incomplete and sometimes controversial. This review discusses the goal of differentiating reactive astrocyte subtypes and states based on composite pictures of molecular expression, cell morphology, cellular interactions, proliferative state, normal functions, and disease-induced dysfunctions. A working model and conceptual framework is presented for characterizing the diversity of astrocyte reactivity.
Astrocyte Diversity in Health and DiseaseAstrocytes (see Glossary) are glial cells of neural progenitor origin that contiguously tile the entire mammalian central nervous system (CNS,) where they constitute one of the most abundant cell populations and provide multiple activities essential for CNS functions in health and disease [1]. Astrocytes interact with both neural and non-neural cells, including neurons and their synapses, oligodendrocytes, oligodendrocyte progenitor cells (OPCs), microglia, various perivascular cells, meningeal fibroblasts, and circulating immune cells. In healthy CNS tissue, astrocytes maintain homeostasis of extracellular fluids, ions, and transmitters [2], provide glucose metabolites as energy substrates to neurons [3], modulate local blood flow [4], help to regulate drainage of interstitial fluid [5], play essential roles in synapse development and plasticity [6], and exhibit dynamic activities that are crucial for neural circuit function, neurological function, and behavior [7].In addition to their functions in healthy CNS, astrocytes exhibit an evolutionarily ancient response to CNS injury and disease, commonly referred to as astrocyte reactivity, that was long regarded as homogeneous and functionally passive [1,[8][9][10]. Instead, over the past 25 years experimental studies using causation-testing transgenic manipulations and other technologies revealed that astrocyte reactivity can lead to a diverse set of potential changes in astrocyte morphology, molecular expression, and functions that can powerfully influence outcomes in all types of CNS disorders including traumatic injury [11][12][13], autoimmune inflammation [14][15][16][17][18], microbial infections [19][20][21], tumor formation [22,23], exposure to environmental toxins [24,25], peripheral metabolic disorders [26], and neurodegenerative diseases [27][28][29]. An extensive body of literature shows that reactive astrocytes can respond to diverse molecular signals that derive from many cell types including neurons, other glia, local stromal cells, microbes, and serum proteins, as well as blood-borne immune cells an...